- Patent Title: 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual system
-
Application No.: US14502907Application Date: 2014-09-30
-
Publication No.: US09701660B2Publication Date: 2017-07-11
- Inventor: Heiko Kroth , Wolfgang Froestl , Andrea Pfeifer , Andreas Muhs
- Applicant: AC Immune S.A.
- Applicant Address: CH Lausanne
- Assignee: AC Immune S.A.
- Current Assignee: AC Immune S.A.
- Current Assignee Address: CH Lausanne
- Agency: Johnson, Marcou & Isaacs, LLC
- Agent F. Brent Nix, Esq.
- Priority: EP09173184 20091015
- Main IPC: A61K31/444
- IPC: A61K31/444 ; C07D401/14 ; C07D471/04 ; G01N33/68
Abstract:
The present invention relates to 2,6-diaminopyridine compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system.
Public/Granted literature
- US20150023950A1 2,6-Diaminopyridine Compounds Suitable for Treating Diseases Associated with Amyloid or Amyloid-Like Proteins or for Treating or Preventing Ocular Diseases or Conditions Associated with a Pathological Abnormality/Change in the Tissue of the Visual System Public/Granted day:2015-01-22
Information query
IPC分类:
